Evidence map›Paper›PMID 34206661›Full record

ArticleBiology2021

Prognostic Impact of

Sherihan AbdelHamid, Hala El-Mesallamy, Hany Abdel Aziz, Abdel-Rahman Zekri

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. PioneeringFrontiers in oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sherihan AbdelHamidDepartment of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
Hala El-MesallamyDepartment of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
Hany Abdel AzizDepartment of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo 11591, Egypt.
Abdel-Rahman ZekriVirology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Giza 11796, Egypt.ORCID 0000-0003-3939-0416
Ain Shams University · EGCairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence on the prognostic relevance of

Indexed as

BRCA1/2 mutationsbreast cancerclinical outcomeEgyptprognosis

Identifiers

PMID34206661
PMCPMC8301143
OpenAlexW3174143341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.